Biologics Is Fastest Growing Segment Fueling The Growth Of The Global Anti-Inflammatory Drugs Market

https://www.coherentmarketinsights.com/market-insight/anti-inflammatory-drugs-market-4327
Anti-Inflammatory Drugs Market 



Market Overview:

Anti-inflammatory drugs are used to treat inflammation and related conditions. These drugs help reduce pain, fever, swelling and other symptoms of inflammation. Some commonly used anti-inflammatory drugs are corticosteroids, NSAIDs and biologics.

Market key trends:
One of the key trends in the anti-inflammatory drugs market is the rise in development and demand of biologics. Biologics such as monoclonal antibodies are increasingly becoming preferred over traditional small molecule drugs due to their high specificity and efficacy. Drugs such as Humira, Remicade and Enbrel have revolutionized the treatment of several chronic inflammatory conditions like rheumatoid arthritis, Crohn’s disease and others. According to research, the biologics segment is expected to grow at the fastest rate during the forecast period owing to promising drug pipelines and benefits of biologics over other drugs.

The global Anti-Inflammatory Drugs Market Size is estimated to be valued at US$ 102248.44 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
Content: The global anti-inflammatory drugs market is segmented based on drug class, indication, route of administration, distribution channel, and geography. Corticosteroids dominated the market in 2021 owing to their wide usage for treating various inflammatory conditions like arthritis, asthma, and skin diseases. Corticosteroids are highly effective anti-inflammatory agents that help reduce inflammation.

Key Takeaways
The global anti-inflammatory drugs market is expected to witness high growth, exhibiting CAGR of 8.6% over the forecast period, due to increasing prevalence of inflammatory disorders globally.

Regional analysis: North America holds the largest share in the anti-inflammatory drugs market due to high healthcare expenditure and presence of major market players in the region. Asia Pacific is expected to witness the fastest growth rate during the forecast period owing to changing lifestyle, increasing healthcare expenditure and growing incidence of inflammatory diseases.

Key players: Key players operating in the anti-inflammatory drugs market include Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy€TMs Laboratories. These players are focusing on new product launches and mergers & acquisitions to expand their presence and strengthen their market position.


Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries